These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3489674)

  • 1. Selection and characterization of transferrin receptor mutants using receptor-specific antibodies.
    Lesley J; Schulte R
    Immunogenetics; 1986; 24(3):163-70. PubMed ID: 3489674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of transferrin receptor-targeted immunotoxins in brain tumor cell lines and pediatric brain tumors.
    Martell LA; Agrawal A; Ross DA; Muraszko KM
    Cancer Res; 1993 Mar; 53(6):1348-53. PubMed ID: 8443815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent cytotoxicity of an antihuman transferrin receptor-ricin A-chain immunotoxin on human glioma cells in vitro.
    Recht LD; Griffin TW; Raso V; Salimi AR
    Cancer Res; 1990 Oct; 50(20):6696-700. PubMed ID: 2208135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selection of cell lines resistant to anti-transferrin receptor antibody: evidence for a mutation in transferrin receptor.
    Lesley JF; Schulte RJ
    Mol Cell Biol; 1984 Sep; 4(9):1675-81. PubMed ID: 6092931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.
    Zovickian J; Johnson VG; Youle RJ
    J Neurosurg; 1987 Jun; 66(6):850-61. PubMed ID: 3033171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell surface receptor directed targeting of toxin to human malaria parasite, Plasmodium falciparum.
    Surolia N; Misquith S
    FEBS Lett; 1996 Oct; 396(1):57-61. PubMed ID: 8906866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional expression of the human transferrin receptor cDNA in Chinese hamster ovary cells deficient in endogenous transferrin receptor.
    McGraw TE; Greenfield L; Maxfield FR
    J Cell Biol; 1987 Jul; 105(1):207-14. PubMed ID: 3611186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of ligand effects in intracellular trafficking of ricin A chain using anti-ricin hybridomas.
    Kornfeld SB; Leonard JE; Mullen MD; Taetle R
    Cancer Res; 1991 Mar; 51(6):1689-93. PubMed ID: 1998959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanization of immunotoxins.
    Rybak SM; Hoogenboom HR; Meade HM; Raus JC; Schwartz D; Youle RJ
    Proc Natl Acad Sci U S A; 1992 Apr; 89(8):3165-9. PubMed ID: 1565609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective inhibition of growing pigment epithelial cells by a receptor-directed immunotoxin.
    Davis AA; Whidby DE; Privette T; Houston LL; Hunt RC
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2514-9. PubMed ID: 2265991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotoxins: selection of cell-surface antigens and their corresponding monoclonal antibodies.
    Bjorn MJ; Villemez CL
    Cancer Treat Res; 1988; 37():255-77. PubMed ID: 2908629
    [No Abstract]   [Full Text] [Related]  

  • 12. Cytoreductive effects of anti-transferrin receptor immunotoxin in a multicellular tumor spheroid model.
    Chignola R; Foroni R; Candiani C; Franceschi A; Pasti M; Stevanoni G; Anselmi C; Tridente G; Colombatti M
    Int J Cancer; 1994 Apr; 57(2):268-74. PubMed ID: 8157364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of an anti-transferrin receptor immunotoxin on normal and leukemic human hematopoietic progenitors.
    Cazzola M; Bergamaschi G; Dezza L; D'Uva R; Ponchio L; Rosti V; Ascari E
    Cancer Res; 1991 Jan; 51(2):536-41. PubMed ID: 1985771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunotoxin composed of a monoclonal antitransferrin receptor antibody linked by a disulfide bond to the ribosome-inactivating protein gelonin: potent in vitro and in vivo effects against human tumors.
    Scott CF; Goldmacher VS; Lambert JM; Jackson JV; McIntyre GD
    J Natl Cancer Inst; 1987 Nov; 79(5):1163-72. PubMed ID: 3500356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotoxins to the murine transferrin receptor: intracavitary therapy of mice bearing syngeneic peritoneal tumors.
    Bjorn MJ; Groetsema G
    Cancer Res; 1987 Dec; 47(24 Pt 1):6639-45. PubMed ID: 3499979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and function of transferrin receptors and their relationship to cell growth.
    Trowbridge IS; Shackelford DA
    Biochem Soc Symp; 1986; 51():117-29. PubMed ID: 3545211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and toxicology of immunotoxins administered into the subarachnoid space in nonhuman primates and rodents.
    Muraszko K; Sung C; Walbridge S; Greenfield L; Dedrick RL; Oldfield EH; Youle RJ
    Cancer Res; 1993 Aug; 53(16):3752-7. PubMed ID: 8339287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of an anti-murine transferrin receptor-ricin A conjugate on bone marrow stem and progenitor cells treated in vitro.
    Lesley J; Domingo DL; Schulte R; Trowbridge IS
    Exp Cell Res; 1984 Feb; 150(2):400-7. PubMed ID: 6319165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation and analysis of somatic cell mutants resistant to toxin conjugates.
    Goldmacher VS
    Cancer Treat Res; 1988; 37():417-30. PubMed ID: 2908637
    [No Abstract]   [Full Text] [Related]  

  • 20. An assay that predicts the ability of monoclonal antibodies to form potent ricin A chain-containing immunotoxins.
    Till M; May RD; Uhr JW; Thorpe PE; Vitetta ES
    Cancer Res; 1988 Mar; 48(5):1119-23. PubMed ID: 3257712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.